Brain scans may reveal if cancer treatment will work
NCT ID NCT04566185
Summary
This study tested whether two types of brain scans (PET and CT perfusion) could predict if patients with recurrent glioblastoma would respond to bevacizumab treatment. Researchers enrolled 14 patients whose brain cancer had returned after standard treatments. The goal was to see if scan results before treatment could identify who would benefit, potentially helping doctors choose the right therapy sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nimes
Nîmes, 30029, France
Conditions
Explore the condition pages connected to this study.